Welcome to our dedicated page for Ge Healthcare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on Ge Healthcare Technologies stock.
GE HealthCare Technologies Inc. (Nasdaq: GEHC) is a global healthcare solutions provider focused on medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services, and data analytics. This news page aggregates company announcements, press releases, and other updates related to GE HealthCare’s business activities and capital markets disclosures.
Visitors can find news about GE HealthCare’s collaborations with health systems, governments, and academic institutions, such as agreements to supply advanced CT scanners under national programs, multi-year care alliances with medical centers, and research initiatives in radiation therapy and oncology. The company also issues news on product and technology developments, including imaging systems, AI-powered reconstruction tools, radiology workflow software, and other innovations that it associates with advancing precision care.
GE HealthCare’s news flow includes corporate and investor-focused items as well. Examples include announcements of upcoming earnings releases, participation in healthcare and investor conferences, and responses to shareholder-related matters such as unsolicited mini-tender offers. These communications provide context on how the company presents its strategy, financing activities, and interactions with the capital markets.
Because GE HealthCare emphasizes integrated solutions across Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, many news items highlight how these businesses work together in specific projects or collaborations. Readers can expect coverage of topics such as AI-enabled imaging, diagnostic access initiatives, training and innovation hubs, and alliances aimed at supporting more efficient and precise care. Investors and observers who follow GEHC news can use this page as a centralized view of the company’s publicly released information and developments over time.
GE HealthCare (Nasdaq: GEHC) announced FDA 510(k) clearances (Feb 19, 2026) for three next‑generation MR innovations: SIGNA Sprint with Freelium (1.5T sealed, helium‑free), SIGNA Bolt (advanced 3T), and SIGNA One (AI workflow ecosystem).
Key benefits claimed include <1% helium use, >5‑hour ride‑through, ~30% lower gradient power, up to 65% peak power reduction, up to 34% smaller equipment room, and AI workflow automation to improve throughput and consistency.
GE HealthCare (Nasdaq: GEHC) announced an approximately $35 million expansion to its BARDA cost-share contract to accelerate development of AI-powered point-of-care ultrasound for trauma assessment and mass-casualty preparedness. The agreement builds on an October 2023 program and funds automated AI tools, lung and intra-abdominal assessment features, ruggedized field devices, and clinician evaluation activities to generate clinical evidence.
The expansion is majority-funded by BARDA and includes federal contract number 75A50123C00035.
GE HealthCare (Nasdaq: GEHC) declared a cash dividend of $0.035 per share for the first quarter of 2026. The dividend is payable on May 15, 2026 to shareholders of record as of April 3, 2026.
GE HealthCare (Nasdaq: GEHC) said members of its management team will present at two upcoming investor conferences: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day on Feb 26, 2026 at 9:30 AM ET and Barclays 28th Annual Global Healthcare Conference on Mar 10, 2026 at 8:00 AM ET.
Webcasts for both events will be available on the company’s investor website on the dates and times listed.
GE HealthCare (Nasdaq: GEHC) launched ReadyFix in the United States on February 9, 2026, a remote fleet management solution to support device uptime and reduce disruptions for cardiac care.
ReadyFix integrates with MAC VU360 resting ECG workstations for real-time remote diagnostics, remote software/configuration management, and intends future compatibility with additional devices and care areas. The release highlights device density (10–15 devices per bed) and workforce strain among biomedical engineers, positioning ReadyFix to help maintain consistent patient care.
GE HealthCare (Nasdaq: GEHC) reported Q4 2025 revenue of $5.7 billion, up 7.1% (organic +4.8%), and full-year 2025 revenue of $20.6 billion, up 4.8% (organic +3.5%).
Q4 diluted EPS was $1.29 (Adjusted EPS $1.44); full‑year diluted EPS was $4.55 (Adjusted EPS $4.59). The company announced 2026 guidance: Adjusted EPS $4.95–$5.15 and adjusted EBIT margin 15.8%–16.1%.
GE HealthCare (Nasdaq: GEHC) announced U.S. FDA 510(k) clearance and CE Mark for Allia Moveo on February 2, 2026, and reported the first global installation at Hôpital Marie-Lannelongue in France and the first U.S. installation at Baylor St. Luke’s Medical Center.
Allia Moveo is a compact, cable-free C-arm platform with AI-driven 3D imaging tools (CleaRecon DLi, Motion Freeze, Metallic Artifact Reduction) and augmented guidance designed to improve mobility, image clarity, and workflow in complex interventional procedures.
GE HealthCare (Nasdaq: GEHC) announced it received an unsolicited mini-tender offer from Potemkin Limited to buy up to 100,000 shares of GE HealthCare common stock for $54.20 per share in cash.
The offer price is approximately 34.77% below the $83.09 closing price on December 8, 2025. GE HealthCare does not endorse the offer, says Potemkin is not affiliated with the company, and recommends stockholders do not tender because the price is well below market and the offer is subject to numerous conditions.
The offer currently expires at 5:00 p.m. ET on June 9, 2026; shareholders who have already tendered may withdraw shares within 14 days after delivery of the acceptance form, per the offer documents.
GE HealthCare (Nasdaq: GEHC) will report its fourth quarter and full year 2025 financial results before market open on February 4, 2026.
The GE HealthCare management team will host a live conference call and webcast on February 4, 2026 at 8:30 a.m. ET / 7:30 a.m. CT. The earnings release, accompanying financial information, and a replay of the webcast will be posted at https://investor.gehealthcare.com/news-events/events.
GE HealthCare (Nasdaq: GEHC) said members of its management team will present at the JP Morgan 44th Annual Healthcare Conference in San Francisco on January 13, 2026 at 10:30 a.m. PT / 1:30 p.m. ET. A live webcast will be available on the company investor website at the scheduled time.